183 related articles for article (PubMed ID: 37954496)
1. N
Wei H; Huang L; Lu Q; Huang Z; Huang Y; Xu Z; Li W; Pu J
J Hepatocell Carcinoma; 2023; 10():1991-2007. PubMed ID: 37954496
[TBL] [Abstract][Full Text] [Related]
2. N
Tan C; Huang Y; Huang Z; Ning Y; Huang L; Wu X; Lu Y; Wei H; Pu J
J Hepatocell Carcinoma; 2023; 10():1479-1495. PubMed ID: 37701563
[TBL] [Abstract][Full Text] [Related]
3. N
Pu J; Xu Z; Huang Y; Nian J; Yang M; Fang Q; Wei Q; Huang Z; Liu G; Wang J; Wu X; Wei H
Cancer Sci; 2023 Sep; 114(9):3649-3665. PubMed ID: 37400994
[TBL] [Abstract][Full Text] [Related]
4. CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation.
Zhang S; Jiang M; Cao H; Xiong J; Xu J
J Hepatocell Carcinoma; 2022; 9():553-569. PubMed ID: 35698644
[TBL] [Abstract][Full Text] [Related]
5. METTL3 and METTL14-mediated N
Wu X; Zeng M; Wei Y; Lu R; Huang Z; Huang L; Huang Y; Lu Y; Li W; Wei H; Pu J
Sci Rep; 2024 Mar; 14(1):6155. PubMed ID: 38486042
[TBL] [Abstract][Full Text] [Related]
6. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.
Wu S; Chen S; Lin N; Yang J
J Cell Mol Med; 2020 Mar; 24(5):3108-3116. PubMed ID: 31970876
[TBL] [Abstract][Full Text] [Related]
9. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
Hu Z; Wang P; Lin J; Zheng X; Yang F; Zhang G; Chen D; Xie J; Gao Z; Peng L; Xie C
Cell Physiol Biochem; 2018; 51(1):470-486. PubMed ID: 30453289
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA NRAV enhances proliferation and invasion of hepatocellular carcinoma cells by modulating the Wnt/β-catenin signaling pathway.
Wang Q; Tang Y; Ge Y; Zhang S; Zheng M
Bioengineered; 2022 Apr; 13(4):10026-10037. PubMed ID: 35436415
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA miR143HG predicts good prognosis and inhibits tumor multiplication and metastasis by suppressing mitogen-activated protein kinase and Wnt signaling pathways in hepatocellular carcinoma.
Lin X; Xiaoqin H; Jiayu C; Li F; Yue L; Ximing X
Hepatol Res; 2019 Aug; 49(8):902-918. PubMed ID: 30945380
[TBL] [Abstract][Full Text] [Related]
14. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
15. KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.
Zhang S; Xu J; Cao H; Jiang M; Xiong J
Front Oncol; 2021; 11():808291. PubMed ID: 35127520
[TBL] [Abstract][Full Text] [Related]
16. LncAY controls BMI1 expression and activates BMI1/Wnt/β-catenin signaling axis in hepatocellular carcinoma.
Chen MH; Fu LS; Zhang F; Yang Y; Wu XZ
Life Sci; 2021 Sep; 280():119748. PubMed ID: 34174322
[TBL] [Abstract][Full Text] [Related]
17. N
Lu J; Ru J; Chen Y; Ling Z; Liu H; Ding B; Jiang Y; Ma J; Zhang D; Ge J; Li Y; Sun F; Chen D; Zheng S; Wu J
Clin Transl Med; 2023 Oct; 13(10):e1451. PubMed ID: 37877357
[TBL] [Abstract][Full Text] [Related]
18. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.
Zhu L; Yang X; Feng J; Mao J; Zhang Q; He M; Mi Y; Mei Y; Jin G; Zhang H
J Transl Med; 2022 May; 20(1):194. PubMed ID: 35509083
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]